FactEvidence 1
leased area672,000 square feet
No public evidence summary is available.
Commercial Observer · 2026-10-21 02:20
View evidence
- MediaCommercial Observer2026-10-21 02:20View source
Company
Revolution Medicines
Structure of Revolution Medicines
Revolution Medicines
Company
2 connections
PeersCompetition and partners
DownstreamCustomers
Relationship began
Revolution MedicinesCompany · 2 connections
Layer 1DownstreamCustomers1
PeersCompetition and partners1
Place in the network
No. 22056 of 43607top 51%
2 direct links
In a group of 322 closely linked entities, around
New links this week
- operates in Colorectal Cancer Market
Weighted by public relations with evidence, recomputed daily.
Relations
Arrows show the direction of the relationship. Filter to focus on a business area.
- Market · Colorectal Cancer MarketEvidence 1Fact90%
View evidence
- CompanyPR Newswire news releases2026-10-19 22:31
key CRC companies including **Johnson & Johnson Innovative Medicine, Shanghai Henlius Biotech, Exelixis, Agenus, Verastem Oncology, Adagene, Summit Therapeutics, AbbVie, Oncolytics Biotech, Sanofi, Revolution Medicines
View source
- Product · zoldonrasibEvidence 1Fact55%
View evidence
- Media钛媒体2026-10-13 10:46View source
- Product · daraxonrasibEvidence 1Fact55%
View evidence
- Media钛媒体2026-10-13 10:46View source
- Company · SanofiEvidence 1Fact55%
View evidence
- Media钛媒体2026-10-14 18:30View source
Showing 1 to 4 of 4
Claims
Read the assertion alongside its sources. Expand a row to inspect the evidence.
FactEvidence 1
operates inColorectal Cancer Market
key CRC companies including **Johnson & Johnson Innovative Medicine, Shanghai Henlius Biotech, Exelixis, Agenus, Verastem Oncology, Adagene, Summit Therapeutics, AbbVie, Oncolytics Biotech, Sanofi, Revolution Medicines
PR Newswire news releases · 2026-10-19 22:31
View evidence
- CompanyPR Newswire news releases2026-10-19 22:31
key CRC companies including **Johnson & Johnson Innovative Medicine, Shanghai Henlius Biotech, Exelixis, Agenus, Verastem Oncology, Adagene, Summit Therapeutics, AbbVie, Oncolytics Biotech, Sanofi, Revolution Medicines
View source
FactEvidence 1
Claims75.5 亿美元
No public evidence summary is available.
钛媒体 · 2026-10-14 18:30
View evidence
- Media钛媒体2026-10-14 18:30View source
FactEvidence 1
ipo近10次
No public evidence summary is available.
钛媒体 · 2026-10-14 18:30
View evidence
- Media钛媒体2026-10-14 18:30View source
FactEvidence 1
agreement withSanofi
No public evidence summary is available.
钛媒体 · 2026-10-14 18:30
View evidence
- Media钛媒体2026-10-14 18:30View source
FactEvidence 1
Claims5000万 美元
No public evidence summary is available.
钛媒体 · 2026-10-14 18:30
View evidence
- Media钛媒体2026-10-14 18:30View source
Showing 1 to 6 of 9
Market and valuation
Valuation data is available on Pro and Research.
Included in ProSuggest a page to watch
Know a page of this company that matters, such as pricing, a changelog, terms or careers? Suggest it. We read every suggestion; a page we add is watched for everyone, and we only count a change when two looks in a row agree.
Not available: Company signals · Financials · Filings · Sites · Guidance